Format

Send to

Choose Destination
J Cell Physiol. 2019 Mar 10. doi: 10.1002/jcp.28384. [Epub ahead of print]

Rhoifolin ameliorates titanium particle-stimulated osteolysis and attenuates osteoclastogenesis via RANKL-induced NF-κB and MAPK pathways.

Liao S1,2, Song F2,3, Feng W1,2, Ding X1,2, Yao J1,2, Song H4, Liu Y1, Ma S1, Wang Z3, Lin X2, Xu J2,3, Zhao J1,2, Liu Q1,2.

Author information

1
Department of Trauma Orthopedic and Hand Surgery, The First Affliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.
2
Guangxi Key Laboratory of Regenerative Medicine, Research Centre for Regenerative Medicine, Guangxi Medical University, Nanning, Guangxi, China.
3
School of Biomedical Sciences, The University of Western Australia, Perth, Western Australia, Australia.
4
Departments of Anesthesiology, The First Affliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China.

Abstract

Prosthesis loosening is a highly troublesome clinical problem following total joint arthroplasty. Wear-particle-induced osteoclastogenesis has been shown to be the primary cause of periprosthetic osteolysis that eventually leads to aseptic prosthesis loosening. Therefore, inhibiting osteoclastogenesis is a promising strategy to control periprosthetic osteolysis. The possible mechanism of action of rhoifolin on osteoclastogenesis and titanium particle-induced calvarial osteolysis was examined in this study. The in vitro study showed that rhoifolin could strongly suppress the receptor activators of nuclear factor-κB (NF-κB) ligand-stimulated osteoclastogenesis, hydroxyapatite resorption, F-actin formation, and the gene expression of osteoclast-related genes. Western blot analysis illustrated that rhoifolin could attenuate the NF-κB and mitogen-activated protein kinase pathways, and the expression of transcriptional factors nuclear factor of activated T cells 1 (NFATc1) and c-Fos. Further studies indicated that rhoifolin inhibited p65 translocation to the nucleus and the activity of NFATc1 and NF-κB rhoifolin could decrease the number of tartrate-resistant acid phosphate-positive osteoclasts and titanium particle-induced C57 mouse calvarial bone loss in vivo. In conclusion, our results suggest that rhoifolin can ameliorate the osteoclasts-stimulated osteolysis, and may be a potential agent for the treatment of prosthesis loosening.

KEYWORDS:

RANKL; osteoclast; rhoifolin; titanium particle

PMID:
30854667
DOI:
10.1002/jcp.28384

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center